Last reviewed · How we verify

NCT07194824: Des-Al-Pen

A Penicillin Allergy Delabeling Inhospital Model Hospitalized Patients

Terminated NA Last updated 13 January 2026
What this trial tests

NA trial testing Pragmatic allergy management according to risk stratification in Allergy Drug in 165 participants. Terminated before completion.

Timeline
4 April 2024
Primary endpoint
23 May 2025
25 May 2025

Quick facts

Lead sponsorAlthaia Xarxa Assistencial Universitària de Manresa
PhaseNA
StatusTerminated
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment165
Start date4 April 2024
Primary completion23 May 2025
Estimated completion25 May 2025
Sites2 locations across Spain

Drugs / interventions tested

Conditions studied

Sponsor

Althaia Xarxa Assistencial Universitària de Manresa

Who can join

18 and older, any sex, with Allergy Drug or Allergy Penicillin. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Design, implementation and analysis of an allergy assessment and management model beta-lactams in hospitalized patients

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Althaia Xarxa Assistencial Universitària de Manresa trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07194824.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing